[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:sarcoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":308,"states":313},"Sarcoma",106,94,[8,16,23,30,36,42,48,54,60,65,71,77,83,89,95,101,107,113,119,125,131,137,143,149,155,161,167,173,179,185,190,196,202,207,213,219,225,231,237,242,248,254,260,266,272,278,284,290,295,301],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT03465592","Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:18:30.351130Z","2026-05-05T02:43:28.498253Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07374848","Phase 1a\u002Fb Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors",[20],"Phase 1","2026-08-26T02:16:34.792807Z","2026-05-05T02:43:28.484817Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT06436612","Study of Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy for Abdominopelvic Sarcomas (MARS Trial)",[27],"Phase 2","2026-08-26T02:18:53.782384Z","2026-05-05T02:43:27.953017Z",{"nct_id":31,"title":32,"phases":33,"status":13,"updated_at":34,"content_modified":35},"NCT04461171","Enhanced Recovery After Surgery in Extremity Sarcoma",[],"2026-08-26T02:16:35.654046Z","2026-04-29T02:57:57.145707Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT03715933","Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas",[20],"2026-08-26T02:15:20.225313Z","2026-07-05T05:32:16.772905Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT06975293","STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas",[12],"2026-08-26T02:16:33.772093Z","2026-05-05T02:43:29.479024Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT06156410","Cabozantinib With Ifosfamide in Relapsed\u002FRefractory Sarcomas",[20],"2026-08-26T02:17:18.747857Z","2026-05-05T02:43:28.669008Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT03886311","Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma",[27],"2026-08-26T02:17:06.985283Z","2026-05-05T02:43:28.539009Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":40,"content_modified":64},"NCT05210374","Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas",[20],"2026-05-05T02:43:27.805890Z",{"nct_id":66,"title":67,"phases":68,"status":13,"updated_at":69,"content_modified":70},"NCT04332874","A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg",[27],"2026-08-26T02:16:50.548894Z","2026-05-05T02:43:27.645373Z",{"nct_id":72,"title":73,"phases":74,"status":13,"updated_at":75,"content_modified":76},"NCT06239272","NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)",[12],"2026-08-26T02:18:06.247899Z","2026-07-19T19:36:05.068230Z",{"nct_id":78,"title":79,"phases":80,"status":13,"updated_at":81,"content_modified":82},"NCT06580002","Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial",[27],"2026-08-26T02:15:04.877798Z","2026-07-19T19:36:05.038415Z",{"nct_id":84,"title":85,"phases":86,"status":13,"updated_at":87,"content_modified":88},"NCT05711615","Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma",[20],"2026-08-26T02:19:30.857183Z","2026-07-05T05:32:16.811405Z",{"nct_id":90,"title":91,"phases":92,"status":13,"updated_at":93,"content_modified":94},"NCT05521984","Targeting Pediatric Brain Tumors and Relapsed\u002FRefractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)",[20],"2026-08-26T02:15:15.642947Z","2026-07-05T05:32:16.804377Z",{"nct_id":96,"title":97,"phases":98,"status":13,"updated_at":99,"content_modified":100},"NCT06571734","XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma",[27],"2026-08-26T02:17:14.343713Z","2026-07-05T05:32:16.766529Z",{"nct_id":102,"title":103,"phases":104,"status":13,"updated_at":105,"content_modified":106},"NCT06021626","A Study of CRD3874-SI in People With Solid Tumors",[20],"2026-08-26T02:16:32.589113Z","2026-07-05T05:32:16.744495Z",{"nct_id":108,"title":109,"phases":110,"status":13,"updated_at":111,"content_modified":112},"NCT07089992","A Study of Pembrolizumab in People With Ultra-Rare Sarcomas",[27],"2026-08-26T02:16:48.735701Z","2026-07-05T05:32:16.733886Z",{"nct_id":114,"title":115,"phases":116,"status":13,"updated_at":117,"content_modified":118},"NCT06789172","A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors",[20],"2026-08-26T02:16:18.872924Z","2026-07-05T05:32:16.698119Z",{"nct_id":120,"title":121,"phases":122,"status":13,"updated_at":123,"content_modified":124},"NCT06242470","A Study of MGC026 in Participants With Advanced Solid Tumors",[20],"2026-08-26T02:16:31.714843Z","2026-05-05T02:43:29.659697Z",{"nct_id":126,"title":127,"phases":128,"status":13,"updated_at":129,"content_modified":130},"NCT06444815","A Study of VET3-TGI in Patients With Solid Tumors",[20],"2026-08-26T02:17:46.653867Z","2026-05-05T02:43:29.507169Z",{"nct_id":132,"title":133,"phases":134,"status":13,"updated_at":135,"content_modified":136},"NCT07132918","HEARTS Trial for Thoracic Cancers",[27],"2026-08-26T02:16:59.895916Z","2026-05-05T02:43:29.372446Z",{"nct_id":138,"title":139,"phases":140,"status":13,"updated_at":141,"content_modified":142},"NCT04771520","Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors",[27],"2026-08-26T02:18:21.216897Z","2026-05-05T02:43:29.157002Z",{"nct_id":144,"title":145,"phases":146,"status":13,"updated_at":147,"content_modified":148},"NCT06910657","IDOV-Immune for Advanced Solid Tumors",[20],"2026-08-26T02:19:09.651016Z","2026-05-05T02:43:28.638930Z",{"nct_id":150,"title":151,"phases":152,"status":13,"updated_at":153,"content_modified":154},"NCT06103669","Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS)",[],"2026-08-26T02:19:28.327680Z","2026-05-05T02:43:28.629957Z",{"nct_id":156,"title":157,"phases":158,"status":13,"updated_at":159,"content_modified":160},"NCT04038619","Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients",[20],"2026-08-26T02:15:54.846520Z","2026-05-05T02:43:28.626402Z",{"nct_id":162,"title":163,"phases":164,"status":13,"updated_at":165,"content_modified":166},"NCT05135975","A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors",[27],"2026-08-26T02:16:46.147215Z","2026-05-05T02:43:28.530799Z",{"nct_id":168,"title":169,"phases":170,"status":13,"updated_at":171,"content_modified":172},"NCT05837767","A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue",[],"2026-08-26T02:15:01.639696Z","2026-05-05T02:43:28.504007Z",{"nct_id":174,"title":175,"phases":176,"status":13,"updated_at":177,"content_modified":178},"NCT06710756","Lead-212 PSV359 Therapy for Patients With Solid Tumors",[12],"2026-08-26T02:19:10.436356Z","2026-05-05T02:43:28.400599Z",{"nct_id":180,"title":181,"phases":182,"status":13,"updated_at":183,"content_modified":184},"NCT04145622","Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors",[12],"2026-08-26T02:19:21.761002Z","2026-05-05T02:43:28.019495Z",{"nct_id":186,"title":187,"phases":188,"status":13,"updated_at":123,"content_modified":189},"NCT04995003","HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma",[20],"2026-05-05T02:43:27.987147Z",{"nct_id":191,"title":192,"phases":193,"status":13,"updated_at":194,"content_modified":195},"NCT05732831","Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors",[12],"2026-08-26T02:18:40.612983Z","2026-05-05T02:43:27.947953Z",{"nct_id":197,"title":198,"phases":199,"status":13,"updated_at":200,"content_modified":201},"NCT04370587","A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors",[12],"2026-08-26T02:18:17.007929Z","2026-05-05T02:43:27.914403Z",{"nct_id":203,"title":204,"phases":205,"status":13,"updated_at":40,"content_modified":206},"NCT05674825","Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Malignancies and Poor Prognoses",[12],"2026-05-05T02:43:27.840688Z",{"nct_id":208,"title":209,"phases":210,"status":13,"updated_at":211,"content_modified":212},"NCT03093116","A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements",[12],"2026-08-26T02:17:38.215063Z","2026-05-05T02:43:27.489051Z",{"nct_id":214,"title":215,"phases":216,"status":13,"updated_at":217,"content_modified":218},"NCT06906900","A Phase I Study of the NovoTTF-200M and Novo TTF-200A Systems for the Treatment of Refractory Spinal Metastasis",[20],"2026-08-26T02:18:51.009190Z","2026-05-05T02:43:27.318476Z",{"nct_id":220,"title":221,"phases":222,"status":13,"updated_at":223,"content_modified":224},"NCT07222735","Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed\u002FRefractory Sarcomas",[20],"2026-08-26T02:17:48.768272Z","2026-05-05T02:43:27.273704Z",{"nct_id":226,"title":227,"phases":228,"status":13,"updated_at":229,"content_modified":230},"NCT05253131","Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas",[27],"2026-08-26T02:15:37.042762Z","2026-05-05T02:43:27.251035Z",{"nct_id":232,"title":233,"phases":234,"status":13,"updated_at":235,"content_modified":236},"NCT06709495","Phase 1\u002F2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas",[12],"2026-08-26T02:16:24.135291Z","2026-05-05T02:43:27.245630Z",{"nct_id":238,"title":239,"phases":240,"status":13,"updated_at":135,"content_modified":241},"NCT07229313","A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors",[20],"2026-05-05T02:43:27.090902Z",{"nct_id":243,"title":244,"phases":245,"status":13,"updated_at":246,"content_modified":247},"NCT05969860","At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer",[27],"2026-08-26T02:17:20.511551Z","2026-05-05T02:43:26.978986Z",{"nct_id":249,"title":250,"phases":251,"status":13,"updated_at":252,"content_modified":253},"NCT05841563","Clinical Trial of PM54 in Advanced Solid Tumors Patients.",[20],"2026-08-26T02:15:18.897219Z","2026-05-05T02:43:26.706220Z",{"nct_id":255,"title":256,"phases":257,"status":13,"updated_at":258,"content_modified":259},"NCT05038150","Study of SGN1 in Patients With Advanced Solid Tumor",[12],"2026-08-26T02:18:36.226508Z","2026-05-05T02:35:31.902772Z",{"nct_id":261,"title":262,"phases":263,"status":13,"updated_at":264,"content_modified":265},"NCT06113809","Palbociclib and Pembrolizumab in Sarcoma",[20],"2026-08-26T02:17:39.857430Z","2026-05-05T02:35:31.898243Z",{"nct_id":267,"title":268,"phases":269,"status":13,"updated_at":270,"content_modified":271},"NCT05672108","Phase II Trial of Lung Chemoemobolization",[27],"2026-08-26T02:14:59.425132Z","2026-05-05T02:35:31.668606Z",{"nct_id":273,"title":274,"phases":275,"status":13,"updated_at":276,"content_modified":277},"NCT07447050","Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial",[27],"2026-08-26T02:17:30.145302Z","2026-05-05T02:43:28.340117Z",{"nct_id":279,"title":280,"phases":281,"status":13,"updated_at":282,"content_modified":283},"NCT07058064","WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)",[],"2026-08-26T02:17:27.435233Z","2026-05-05T02:43:29.073081Z",{"nct_id":285,"title":286,"phases":287,"status":13,"updated_at":288,"content_modified":289},"NCT04719156","Fluorescent Intra-operative Tumor Margin Examination",[27],"2026-08-26T02:18:47.742071Z","2026-05-05T02:43:26.745834Z",{"nct_id":291,"title":292,"phases":293,"status":13,"updated_at":258,"content_modified":294},"NCT01542879","Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer",[12],"2026-05-05T02:43:28.187004Z",{"nct_id":296,"title":297,"phases":298,"status":13,"updated_at":299,"content_modified":300},"NCT04621435","Imaging of Solid Tumors Using FAP-2286",[20],"2026-08-26T02:15:34.659160Z","2026-06-16T05:54:07.905981Z",{"nct_id":302,"title":303,"phases":304,"status":13,"updated_at":306,"content_modified":307},"NCT06915727","An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors",[305],"Phase 3","2026-08-26T02:17:00.709807Z","2026-05-05T02:43:27.987617Z",[309],{"biomarker":310,"count":311,"slug":312},"Prolyl Endopeptidase FAP",3,"prolyl-endopeptidase-fap",[314,318,322,326,330,334,338,342,345,349,353,357,360,364,367,370,373,377,381,384,387,390,393,397],{"state":315,"count":316,"slug":317},"California",34,"california",{"state":319,"count":320,"slug":321},"Texas",27,"texas",{"state":323,"count":324,"slug":325},"New York",26,"new-york",{"state":327,"count":328,"slug":329},"Florida",18,"florida",{"state":331,"count":332,"slug":333},"Ohio",17,"ohio",{"state":335,"count":336,"slug":337},"Massachusetts",16,"massachusetts",{"state":339,"count":340,"slug":341},"Missouri",15,"missouri",{"state":343,"count":340,"slug":344},"Pennsylvania","pennsylvania",{"state":346,"count":347,"slug":348},"North Carolina",13,"north-carolina",{"state":350,"count":351,"slug":352},"Tennessee",12,"tennessee",{"state":354,"count":355,"slug":356},"Colorado",11,"colorado",{"state":358,"count":355,"slug":359},"Michigan","michigan",{"state":361,"count":362,"slug":363},"Illinois",10,"illinois",{"state":365,"count":362,"slug":366},"Maryland","maryland",{"state":368,"count":362,"slug":369},"Minnesota","minnesota",{"state":371,"count":362,"slug":372},"New Jersey","new-jersey",{"state":374,"count":375,"slug":376},"Virginia",9,"virginia",{"state":378,"count":379,"slug":380},"Arizona",6,"arizona",{"state":382,"count":379,"slug":383},"District of Columbia","district-of-columbia",{"state":385,"count":379,"slug":386},"Indiana","indiana",{"state":388,"count":379,"slug":389},"Oregon","oregon",{"state":391,"count":379,"slug":392},"Wisconsin","wisconsin",{"state":394,"count":395,"slug":396},"Alabama",5,"alabama",{"state":398,"count":395,"slug":399},"Georgia","georgia"]